Grants paid by Male Contraceptive Initiative
EIN 47-1124856 · Durham, NC · Form 990, Schedule I · NTEE R61
Male Contraceptive Initiative of Durham, NC (EIN 47-1124856) reported 39 grants paid totaling $8,554,924 to 25 recipients in tax years 2018–2024, on Form 990, Schedule I. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$8,554,924
39 grants
Recipients
25
distinct organizations
Tax years
2018–2024
5 filings in the corpus
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2018 | 4 | $475,000 | — |
| 2020 | 7 | $1,295,000 | — |
| 2022 | 7 | $1,990,875 | — |
| 2023 | 16 | $4,100,549 | — |
| 2024 | 5 | $693,500 | — |
Top recipients
The 25 recipients receiving the most from Male Contraceptive Initiative, by grants paid, out of 25 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| Eppin Pharma Inc 46-4839176 | A | Chapel Hill, NC | 3 | $1,466,000 | 2023 |
| Contraceptive Accelerator Network 87-4699751 | A | Apex, NC | 2 | $1,007,800 | 2023 |
| Weill Cornell Medical College 13-1623978 | A | New York, NY | 2 | $910,875 | 2023 |
| Yourchoice Therapeutics 82-3967378 | A | Berkley, CA | 2 | $800,000 | 2023 |
| University of Minnesota 41-6007513 | A | Minneapolis, MN | 3 | $660,000 | 2024 |
| Sacyl Pharmaceuticals 88-4091587 | A | Old Greenwich, CT | 2 | $545,399 | 2024 |
| Next Life Sciences Inc 87-2916663 | A | San Luis Obispo, CA | 1 | $400,000 | 2023 |
| Baylor College of Medicine 74-1613878 | A | Houston, TX | 3 | $400,000 | 2023 |
| Venn Foundation 81-4476503 | A | Saint Paul, MN | 1 | $345,000 | 2020 |
| Vibliome Therapeutics 82-2845964 | A | Bozeman, MT | 2 | $325,000 | 2020 |
| Yale University 06-0646973 | A | New Haven, CT | 2 | $270,000 | 2023 |
| Outsight 4 Development 85-3383666 | A | Columbus, IN | 2 | $227,350 | 2023 |
| University of Massachusetts 04-6002284 | A | Amherst, MA | 1 | $200,000 | 2023 |
| Boston University 04-2103547 | A | Boston, MA | 1 | $150,000 | 2023 |
| Emory University 58-0566256 | A | Atlanta, GA | 2 | $150,000 | 2023 |
| Stanford University 94-1156365 | A | Stanford, CA | 1 | $120,000 | 2023 |
| Cornell University 15-0532082 | A | Ithaca, NY | 1 | $100,000 | 2024 |
| Revolution Contraceptives LLC 90-1019349 | A | San Francisco, CA | 1 | $100,000 | 2020 |
| University of Nevada Reno 88-0387186 | A | Reno, NV | 1 | $100,000 | 2018 |
| Contraline 81-5416830 | A | Charlottesville, VA | 1 | $100,000 | 2018 |
| Wayne State University 38-6028429 | A | Detroit, MI | 1 | $75,000 | 2020 |
| Ucsf 94-6036493 | A | San Francisco, CA | 1 | $63,000 | 2023 |
| Anther 99-3919709 | A | Bozeman, MT | 1 | $23,500 | 2024 |
| Chicago University 36-2177139 | A | Chicago, IL | 1 | $10,000 | 2024 |
| Society for the Study of Reproducti 38-6144910 | A | Reston, VA | 1 | $6,000 | 2023 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 39 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | Sacyl Pharmaceuticals Old Greenwich, CT | A | $400,000 | paid | NONCLINICAL RESEARCH | 202503189349308450 |
| 2024 | University of Minnesota Minneapolis, MN | A | $160,000 | paid | NONCLINICAL RESEARCH | 202503189349308450 |
| 2024 | Cornell University Ithaca, NY | A | $100,000 | paid | NONCLINICAL RESEARCH | 202503189349308450 |
| 2024 | Anther Bozeman, MT | A | $23,500 | paid | TECHNOLOGY EXPANSION | 202503189349308450 |
| 2024 | Chicago University Chicago, IL | A | $10,000 | paid | NONCLINICAL RESEARCH | 202503189349308450 |
| 2023 | Yourchoice Therapeutics Berkley, CA | A | $650,000 | paid | NONCLINICAL RESEARCH | 202403209349305385 |
| 2023 | Weill Cornell Medical College New York, NY | A | $620,000 | paid | NONCLINICAL RESEARCH | 202403209349305385 |
| 2023 | Eppin Pharma Inc Chapel Hill, NC | A | $616,000 | paid | NONCLINICAL RESEARCH | 202403209349305385 |
| 2023 | Next Life Sciences Inc San Luis Obispo, CA | A | $400,000 | paid | NONCLINICAL RESEARCH | 202403209349305385 |
| 2023 | University of Minnesota Minneapolis, MN | A | $400,000 | paid | NONCLINICAL RESEARCH | 202403209349305385 |
| 2023 | Contraceptive Accelerator Network Apex, NC | A | $257,800 | paid | NONCLINICAL RESEARCH | 202403209349305385 |
| 2023 | University of Massachusetts Amherst, MA | A | $200,000 | paid | NONCLINICAL RESEARCH | 202403209349305385 |
| 2023 | Yale University New Haven, CT | A | $195,000 | paid | NONCLINICAL RESEARCH | 202403209349305385 |
| 2023 | Boston University Boston, MA | A | $150,000 | paid | NONCLINICAL RESEARCH | 202403209349305385 |
| 2023 | Sacyl Pharmaceuticals Old Greenwich, CT | A | $145,399 | paid | NONCLINICAL RESEARCH | 202403209349305385 |
| 2023 | Outsight 4 Development Columbus, IN | A | $127,350 | paid | NONCLINICAL RESEARCH | 202403209349305385 |
| 2023 | Stanford University Stanford, CA | A | $120,000 | paid | NONCLINICAL RESEARCH | 202403209349305385 |
| 2023 | Emory University Atlanta, GA | A | $75,000 | paid | NONCLINICAL RESEARCH | 202403209349305385 |
| 2023 | Baylor College of Medicine Houston, TX | A | $75,000 | paid | NONCLINICAL RESEARCH | 202403209349305385 |
| 2023 | Ucsf San Francisco, CA | A | $63,000 | paid | NONCLINICAL RESEARCH | 202403209349305385 |
| 2023 | Society for the Study of Reproducti Reston, VA | A | $6,000 | paid | SCHOLARSHIP | 202403209349305385 |
| 2022 | Contraceptive Accelerator Network Apex, NC | A | $750,000 | paid | Nonclincial Research Advancement | 202313189349310741 |
| 2022 | Eppin Pharma Inc Chapel Hill, NC | A | $550,000 | paid | Nonclincial Research Advancement | 202313189349310741 |
| 2022 | Weill Cornell Medical College New York, NY | A | $290,875 | paid | Nonclincial Research Advancement | 202313189349310741 |
| 2022 | Yourchoice Therapeutics Berkley, CA | A | $150,000 | paid | Nonclincial Research Advancement | 202313189349310741 |
| 2022 | Outsight 4 Development Columbus, IN | A | $100,000 | paid | Nonclincial Research Advancement | 202313189349310741 |
| 2022 | Baylor College of Medicine Houston, TX | A | $75,000 | paid | Nonclincial Research Advancement | 202313189349310741 |
| 2022 | Yale University New Haven, CT | A | $75,000 | paid | Nonclincial Research Advancement | 202313189349310741 |
| 2020 | Venn Foundation Saint Paul, MN | A | $345,000 | paid | Nonclinical Research Advancement | 202143029349301404 |
| 2020 | Eppin Pharma Inc Chapel Hill, NC | A | $300,000 | paid | Nonclinical Research Advancement | 202143029349301404 |
| 2020 | Baylor College of Medicine Houston, TX | A | $250,000 | paid | Nonclinical Research Advancement | 202143029349301404 |
| 2020 | Vibliome Therapeutics Bozeman, MT | A | $150,000 | paid | Nonclinical Research Advancement | 202143029349301404 |
| 2020 | Revolution Contraceptives LLC San Francisco, CA | A | $100,000 | paid | Nonclinical Research Advancement | 202143029349301404 |
| 2020 | Wayne State University Detroit, MI | A | $75,000 | paid | Nonclinical Research Advancement | 202143029349301404 |
| 2020 | Emory University Atlanta, GA | A | $75,000 | paid | Nonclinical Research Advancement | 202143029349301404 |
| 2018 | Vibliome Therapeutics Inc Bozeman, MT | A | $175,000 | paid | RESEARCH ADVANCEMENT EARLY STAGE MALE CO | 201902569349300485 |
| 2018 | University of Nevada Reno Reno, NV | A | $100,000 | paid | RESEARCH ADVANCEMENT EARLY STAGE MALE CO | 201902569349300485 |
| 2018 | Contraline Charlottesville, VA | A | $100,000 | paid | RESEARCH ADVANCEMENT EARLY STAGE MALE CO | 201902569349300485 |
| 2018 | University of Minnesota Minneapolis, MN | A | $100,000 | paid | RESEARCH ADVANCEMENT EARLY STAGE MALE CO | 201902569349300485 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990 | 2024 | 2024-12-31 | not stated | 2024v5.0 | 202503189349308450 |
| 990 | 2023 | 2023-12-31 | not stated | 2023v5.0 | 202403209349305385 |
| 990 | 2022 | 2022-12-31 | not stated | 2022v5.0 | 202313189349310741 |
| 990 | 2020 | 2020-12-31 | not stated | 2020v4.1 | 202143029349301404 |
| 990 | 2018 | 2018-12-31 | not stated | 2018v3.1 | 201902569349300485 |
Derived from IRS Form 990 e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/471124856.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.